Randomised Controlled Trial on Virechana Followed by Kanchanar Guggul in Hypothyroidism Specifically on Thyroid Stimulating Hormone.

Self Pavan Dnyandeo Sushir PG Kayachikitsa Scholar0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1)Patients having clinical features of hypothyroidism and fulfilling diagnostic criteria.
•2)The patient having serum thyroid stimulating hormone value in between 10ÂµIU/ml to 50ÂµIU/ml.
•3)Patients of either gender, aged between 18- 60 years irrespective of caste, religion, socio economic and educational status.
•4)Those patients of newly diagnosed with hypothyroidism who are willing to participate in trial and ready to give written consent.
•5)Those who are fit for Virechana according to classics. [25]
•6)Patients with controlled hypertension (Blood pressure <150/90mm of Hg) and diabetes mellitus (F <130mg/dl and PP <180mg/dl).

•1)Patients not willing for trial.
•2)Patients below 18 years and above 60 years.
•3)Patients having uncontrolled hypertension, diabetes mellitus, Renal failure and any other systemic disease.
•4)Patients suffering from congenital hypothyroidism, neoplasia, toxic goitre.
•5)Patients on prolonged medication ( >6 weeks) with corticosteroid or any other drug that may have an influence on the outcome of study.
•6)Pregnant females and lactating mothers.
•7)Patients who are currently participating in other clinical trials (since last six months).
•8)Patients who have under gone any type of thyroid surgery.
•9)Those who are not fit for Virechana according to classics. [26]
•10)Patient with noncompliance will be excluded.

发起方

Self Pavan Dnyandeo Sushir PG Kayachikitsa Scholar